Literature DB >> 19824883

A one-step exclusion-binding procedure for the purification of functional heavy-chain and mammalian-type gamma-globulins from camelid sera.

Michel R Blanc1, Abdelhaq Anouassi, Mohanad Ahmed Abed, Guillaume Tsikis, Sylvie Canepa, Valérie Labas, Maya Belghazi, Gilles Bruneau.   

Abstract

A new approach has recently been proposed for the purification of 'mammalian-type' IgG, consisting of exclusion binding. The technique uses a gel ('Melon gel'; Pierce) that binds to all plasma proteins, but not to IgGs, thus allowing IgGs to be recovered in the FT (flow-through) fraction. Here, the technique was applied to camelid IgGs, which are known to be composed of not only classic mammalian-type IgGs (IgG1) but also HC-IgGs (heavy chain IgGs). Both mammalian type and HC-IgGs can be purified in the FT fraction of dromedary (Camelus dromedarius) plasma samples with less than 8.5% contamination, by making minor improvements to the conditions recommended by the manufacturer. The contaminant proteins, as determined by LC-MS/MS (liquid chromatography-tandem MS), are mainly transferrin and albumin. The recovery rate is elevated for both types of IgGs (95+/-14% and 88+/-25% for IgG1 and HC-IgGs respectively). IgGs thus purified maintain their ability to bind to their antigen, as measured by surface plasmon resonance and Western ligand blotting. Furthermore, IgGs can be purified from plasma samples of all camelid species in a similar manner, although the ratio of HC-IgGs to total IgGs was lower for Lama (llama) and Vicugna (vicuña) than for Camelus species. The 'Melon gel' technique can thus be used to satisfactorily purify IgG1 and HC-IgGs from all camelid species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19824883     DOI: 10.1042/BA20090208

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  13 in total

1.  Quantitative Detection of Fipronil and Fipronil-Sulfone in Sera of Black-Tailed Prairie Dogs and Rats after Oral Exposure to Fipronil by Camel Single-Domain Antibody-Based Immunoassays.

Authors:  Kai Wang; Natalia Vasylieva; Debin Wan; David A Eads; Jun Yang; Tyler Tretten; Bogdan Barnych; Ji Li; Qing X Li; Shirley J Gee; Bruce D Hammock; Ting Xu
Journal:  Anal Chem       Date:  2018-12-21       Impact factor: 6.986

2.  Characterization of rabbit polyclonal antibody against camel recombinant nanobodies.

Authors:  Houssam-Eddin Khalaf; Hassan Al-Bouqaee; Manal Hwijeh; Abdul Qader Abbady
Journal:  Open Life Sci       Date:  2022-06-15       Impact factor: 1.311

3.  The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury.

Authors:  Alice Capuz; Mélodie-Anne Karnoub; Sylvain Osien; Mélanie Rose; Céline Mériaux; Isabelle Fournier; David Devos; Fabien Vanden Abeele; Franck Rodet; Dasa Cizkova; Michel Salzet
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

4.  Development of a one-step immunoassay for triazophos using camel single-domain antibody-alkaline phosphatase fusion protein.

Authors:  Kai Wang; Zhiping Liu; Guochun Ding; Ji Li; Natalia Vasylieva; Qing X Li; Dongyang Li; Shirley J Gee; Bruce D Hammock; Ting Xu
Journal:  Anal Bioanal Chem       Date:  2019-02-01       Impact factor: 4.142

5.  Landscape of variable domain of heavy-chain-only antibody repertoire from alpaca.

Authors:  Zhui Tu; Xiaoqiang Huang; Jinheng Fu; Na Hu; Wei Zheng; Yanping Li; Yang Zhang
Journal:  Immunology       Date:  2020-06-30       Impact factor: 7.397

6.  Nanobodies as modulators of inflammation: potential applications for acute brain injury.

Authors:  Björn Rissiek; Friedrich Koch-Nolte; Tim Magnus
Journal:  Front Cell Neurosci       Date:  2014-10-21       Impact factor: 5.505

Review 7.  Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.

Authors:  Gualberto Gonzalez-Sapienza; Martín A Rossotti; Sofía Tabares-da Rosa
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

Review 8.  Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases.

Authors:  Carla F C Fernandes; Soraya Dos S Pereira; Marcos B Luiz; Juliana P Zuliani; Gilvan P Furtado; Rodrigo G Stabeli
Journal:  Front Immunol       Date:  2017-06-09       Impact factor: 7.561

9.  Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.

Authors:  Mehdi Arbabi-Ghahroudi
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

10.  Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus.

Authors:  Shu Xu; Hong Yang; Yue Zhuo; Yangsheng Yu; Hongyan Liao; Song Li; Yinshi Yue; Kaihong Su; Zhixin Zhang
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.